parkinson glutathione oxidative ipsc crispr Frontiers Frontiers | Mitochondrial Dysfunction in
Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy Parkinson's disease linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons: Neuron CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells PMC
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




